[
  {
    "ts": null,
    "headline": "3 Dividend Stocks to Double Up on Right Now",
    "summary": "After recently coming under pressure, these three dividend stocks have both yield and rebound potential.",
    "url": "https://finnhub.io/api/news?id=af23d27133a895f2bc131d802c0154d5aea495eeaeea93b32d3a8af7010542e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765478100,
      "headline": "3 Dividend Stocks to Double Up on Right Now",
      "id": 137760431,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "After recently coming under pressure, these three dividend stocks have both yield and rebound potential.",
      "url": "https://finnhub.io/api/news?id=af23d27133a895f2bc131d802c0154d5aea495eeaeea93b32d3a8af7010542e2"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Kings: 3 Ideal Buys In 56 For December",
    "summary": "Dividend Kings remain largely overvalued, but sixâincluding MO, UVV, HRL, KVUE, CDUAF, and UBSIâare now fairly priced with yields (from $1k invested) exceeding share prices. Read more here.",
    "url": "https://finnhub.io/api/news?id=705979bdaa6652e11a0521056e8a9084adc1bc3a32693b0bb5289d13eedc0cd7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765475412,
      "headline": "Dividend Kings: 3 Ideal Buys In 56 For December",
      "id": 137762814,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1451802947/image_1451802947.jpg?io=getty-c-w1536",
      "related": "KVUE",
      "source": "SeekingAlpha",
      "summary": "Dividend Kings remain largely overvalued, but sixâincluding MO, UVV, HRL, KVUE, CDUAF, and UBSIâare now fairly priced with yields (from $1k invested) exceeding share prices. Read more here.",
      "url": "https://finnhub.io/api/news?id=705979bdaa6652e11a0521056e8a9084adc1bc3a32693b0bb5289d13eedc0cd7"
    }
  },
  {
    "ts": null,
    "headline": "Guggenheim Highlights Growth Potential in Johnson & Johnson (JNJ), Maintains Buy",
    "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Stocks to Buy for the Long Term. On December 5, Guggenheim boosted the firm’s price target on Johnson & Johnson (NYSE:JNJ) to $227 from $206 and maintained a Buy rating on the shares. According to the analyst research note, the update came after the firm […]",
    "url": "https://finnhub.io/api/news?id=2aff5c5a74d0293cad7c1413cfd9b2a95fdd966a7369365fd04efe019d6770e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765439416,
      "headline": "Guggenheim Highlights Growth Potential in Johnson & Johnson (JNJ), Maintains Buy",
      "id": 137755852,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Stocks to Buy for the Long Term. On December 5, Guggenheim boosted the firm’s price target on Johnson & Johnson (NYSE:JNJ) to $227 from $206 and maintained a Buy rating on the shares. According to the analyst research note, the update came after the firm […]",
      "url": "https://finnhub.io/api/news?id=2aff5c5a74d0293cad7c1413cfd9b2a95fdd966a7369365fd04efe019d6770e7"
    }
  }
]